📣 VC round data is live. Check it out!
- Public Comps
- Sopharma Properties
Sopharma Properties Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sopharma Properties and similar public comparables like Saga Pure, Advero Properties, FII BTG Pactual Agro Logistica, Ryder Capital and more.
Sopharma Properties Overview
About Sopharma Properties
Sopharma Properties REIT is a special purpose investment company for securitization of real estate.
Founded
2006
HQ

Employees
1
Website
Sectors
Financials (FY)
EV
$106M
Valuation Multiples
Start free trialSopharma Properties Financials
Sopharma Properties reported last fiscal year revenue of $9M and EBITDA of $8M.
In the same fiscal year, Sopharma Properties generated $7M in gross profit, $8M in EBITDA, and $8M in net income.
Sopharma Properties P&L
In the most recent fiscal year, Sopharma Properties reported revenue of $9M and EBITDA of $8M.
Sopharma Properties is profitable as of last fiscal year, with gross margin of 78%, EBITDA margin of 98%, and net margin of 98%.
Financial data powered by Morningstar, Inc.
Sopharma Properties Stock Performance
Sopharma Properties has current market cap of $106M, and enterprise value of $106M.
Market Cap Evolution
Sopharma Properties' stock price is $4.82.
Sopharma Properties share price decreased by 11.0% in the last 30 days, and by 49.4% in the last year.
Sopharma Properties has an EPS (earnings per share) of $0.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $106M | $106M | -1.5% | -11.0% | -12.8% | -49.4% | $0.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSopharma Properties Valuation Multiples
Sopharma Properties trades at 12.3x EV/Revenue multiple, and 12.5x EV/EBITDA.
Sopharma Properties Financial Valuation Multiples
As of June 3, 2026, Sopharma Properties has market cap of $106M and EV of $106M.
Sopharma Properties has a P/E ratio of 12.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sopharma Properties Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sopharma Properties Margins & Growth Rates
In the most recent fiscal year, Sopharma Properties reported gross margin of 78%, EBITDA margin of 98%, and net margin of 98%.
Sopharma Properties Margins
Sopharma Properties Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Properties Operational KPIs
Sopharma Properties' revenue per employee in the last FY averaged $8.6M, while opex per employee averaged $1.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Properties Competitors
Sopharma Properties competitors include Saga Pure, Advero Properties, FII BTG Pactual Agro Logistica, Ryder Capital, Bailador, FII Rio Bravo Renda Corporativa, Bulgarian Real Estate Fund, IBI Lion Socimi, Itau Total Return FII and Monroe Cap.
Most Sopharma Properties public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 34.7x | - | 33.4x | - | |||
| 22.5x | - | 48.4x | - | |||
| 8.9x | - | 10.2x | - | |||
| 37.9x | - | - | - | |||
| 3.7x | - | - | - | |||
| 8.3x | - | - | - | |||
| 3.6x | - | 7.0x | - | |||
| 21.9x | - | 26.6x | - | |||
This data is available for Pro users. Sign up to see all Sopharma Properties competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sopharma Properties
| When was Sopharma Properties founded? | Sopharma Properties was founded in 2006. |
| Where is Sopharma Properties headquartered? | Sopharma Properties is headquartered in Bulgaria. |
| How many employees does Sopharma Properties have? | As of today, Sopharma Properties has over 1 employees. |
| Is Sopharma Properties publicly listed? | Yes, Sopharma Properties is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Sopharma Properties? | Sopharma Properties trades under SFI ticker. |
| When did Sopharma Properties go public? | Sopharma Properties went public in 2006. |
| Who are competitors of Sopharma Properties? | Sopharma Properties main competitors include Saga Pure, Advero Properties, FII BTG Pactual Agro Logistica, Ryder Capital, Bailador, FII Rio Bravo Renda Corporativa, Bulgarian Real Estate Fund, IBI Lion Socimi, Itau Total Return FII, Monroe Cap. |
| What is the current market cap of Sopharma Properties? | Sopharma Properties' current market cap is $106M. |
| What is the current revenue of Sopharma Properties? | Sopharma Properties' last fiscal year revenue is $9M. |
| What is the current EV/Revenue multiple of Sopharma Properties? | Current revenue multiple of Sopharma Properties is 12.3x. |
| Is Sopharma Properties profitable? | No, Sopharma Properties is not profitable. |
| How many companies Sopharma Properties has acquired to date? | Sopharma Properties hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Sopharma Properties has invested to date? | Sopharma Properties hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Sopharma Properties
Lists including Sopharma Properties
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.